αTrop2/αCD3 bispecific protein engager-armed T cells (BATs) exhibit potent antitumor activity against nasopharyngeal carcinoma
Abstract Nasopharyngeal carcinoma (NPC) remains a highly aggressive malignancy with poor outcomes in advanced and recurrent disease. Although immune checkpoint inhibitors combined with chemotherapy improve survival, many patients still experience relapse or disease progression. Here, we developed a...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer
2026-05-01
|
| Serier: | Cancer Immunology, Immunotherapy |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s00262-026-04406-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
